Z-1968-2019 Class II Terminated

Recalled by Pharmaceutical Innovations, Inc. — Newark, NJ

FDA device recall Z-1968-2019 was initiated by Pharmaceutical Innovations, Inc. on Jun 19, 2019 and is designated Class II. Reason for recall: Potential for failed stability antimicrobial effectiveness testing. The recall status is terminated (terminated Jul 29, 2020). Affected quantity: 87140.

Recall details

Product Type
Devices
Report Date
Jul 24, 2019
Initiation Date
Jun 19, 2019
Termination Date
Jul 29, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
87140

Product description

Alpha Conducting solution product codes:3310-15 ACS - Product Usage: Electrode conductivity spray solution.

Reason for recall

Potential for failed stability antimicrobial effectiveness testing.

Distribution pattern

US nationwide distribution including the states of AZ, CA, CT, FL, IL, MA, MI, MN, NC, NJ, NY, OH, PA, RI, TX, TN, VT, WV. Distributed Internationally to accounts in Australia, France, Germany, Hong Kong, Saudi Arabia and Canada.

Code information

Lot # 081914-15, 111715-15, 070116-15, 020117-15, 080117-15, 010118-15, 041618-15, 041618A-15, 071618-15, 102018-15

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1968-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1968-2019. Report a data issue: hello@regdatalab.com.